Click for best price
Canine Stem Cell Therapy Market Size, Share 2022
The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.
This report contains market size and forecasts of Canine Stem Cell Therapy in Global, including the following market information:
Global top five companies in 2021 (%)
The global Canine Stem Cell Therapy market was valued at 103.2 million in 2021 and is projected to reach US$ 121 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Allogeneic Stem Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Canine Stem Cell Therapy include VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix and Magellan Stem Cells, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Canine Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Canine Stem Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Canine Stem Cell Therapy Market Segment Percentages, by Type, 2021 (%)
- Allogeneic Stem Cells
- Autologous Stem cells
Global Canine Stem Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Canine Stem Cell Therapy Market Segment Percentages, by Application, 2021 (%)
- Veterinary Hospitals
- Veterinary Clinics
- Veterinary Research Institutes
Global Canine Stem Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Canine Stem Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Canine Stem Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Canine Stem Cell Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- VETSTEM BIOPHARMA
- Cell Therapy Sciences
- Regeneus
- Aratana Therapeutics
- Medivet Biologics
- Okyanos
- Vetbiologics
- VetMatrix
- Magellan Stem Cells
- ANIMAL CELL THERAPIES
- Stemcellvet
| Report Attributes |
Report Details |
| Report Title |
Canine Stem Cell Therapy Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Canine Stem Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Canine Stem Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Canine Stem Cell Therapy Overall Market Size
2.1 Global Canine Stem Cell Therapy Market Size: 2021 VS 2028
2.2 Global Canine Stem Cell Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Canine Stem Cell Therapy Players in Global Market
3.2 Top Global Canine Stem Cell Therapy Companies Ranked by Revenue
3.3 Global Canine Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Canine Stem Cell Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Canine Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Canine Stem Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Canine Stem Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Canine Stem Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Canine Stem Cell Therapy Market Size Markets, 2021 & 2028
4.1.2 Allogeneic Stem Cells
4.1.3 Autologous Stem cells
4.2 By Type - Global Canine Stem Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Canine Stem Cell Therapy Revenue, 2017-2022
4.2.2 By Type - Global Canine Stem Cell Therapy Revenue, 2023-2028
4.2.3 By Type - Global Canine Stem Cell Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Canine Stem Cell Therapy Market Size, 2021 & 2028
5.1.2 Veterinary Hospitals
5.1.3 Veterinary Clinics
5.1.4 Veterinary Research Institutes
5.2 By Application - Global Canine Stem Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Canine Stem Cell Therapy Revenue, 2017-2022
5.2.2 By Application - Global Canine Stem Cell Therapy Revenue, 2023-2028
5.2.3 By Application - Global Canine Stem Cell Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Canine Stem Cell Therapy Market Size, 2021 & 2028
6.2 By Region - Global Canine Stem Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Canine Stem Cell Therapy Revenue, 2017-2022
6.2.2 By Region - Global Canine Stem Cell Therapy Revenue, 2023-2028
6.2.3 By Region - Global Canine Stem Cell Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Canine Stem Cell Therapy Revenue, 2017-2028
6.3.2 US Canine Stem Cell Therapy Market Size, 2017-2028
6.3.3 Canada Canine Stem Cell Therapy Market Size, 2017-2028
6.3.4 Mexico Canine Stem Cell Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Canine Stem Cell Therapy Revenue, 2017-2028
6.4.2 Germany Canine Stem Cell Therapy Market Size, 2017-2028
6.4.3 France Canine Stem Cell Therapy Market Size, 2017-2028
6.4.4 U.K. Canine Stem Cell Therapy Market Size, 2017-2028
6.4.5 Italy Canine Stem Cell Therapy Market Size, 2017-2028
6.4.6 Russia Canine Stem Cell Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Canine Stem Cell Therapy Market Size, 2017-2028
6.4.8 Benelux Canine Stem Cell Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Canine Stem Cell Therapy Revenue, 2017-2028
6.5.2 China Canine Stem Cell Therapy Market Size, 2017-2028
6.5.3 Japan Canine Stem Cell Therapy Market Size, 2017-2028
6.5.4 South Korea Canine Stem Cell Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Canine Stem Cell Therapy Market Size, 2017-2028
6.5.6 India Canine Stem Cell Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Canine Stem Cell Therapy Revenue, 2017-2028
6.6.2 Brazil Canine Stem Cell Therapy Market Size, 2017-2028
6.6.3 Argentina Canine Stem Cell Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Canine Stem Cell Therapy Revenue, 2017-2028
6.7.2 Turkey Canine Stem Cell Therapy Market Size, 2017-2028
6.7.3 Israel Canine Stem Cell Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Canine Stem Cell Therapy Market Size, 2017-2028
6.7.5 UAE Canine Stem Cell Therapy Market Size, 2017-2028
7 Players Profiles
7.1 VETSTEM BIOPHARMA
7.1.1 VETSTEM BIOPHARMA Corporate Summary
7.1.2 VETSTEM BIOPHARMA Business Overview
7.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Major Product Offerings
7.1.4 VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.1.5 VETSTEM BIOPHARMA Key News
7.2 Cell Therapy Sciences
7.2.1 Cell Therapy Sciences Corporate Summary
7.2.2 Cell Therapy Sciences Business Overview
7.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Major Product Offerings
7.2.4 Cell Therapy Sciences Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.2.5 Cell Therapy Sciences Key News
7.3 Regeneus
7.3.1 Regeneus Corporate Summary
7.3.2 Regeneus Business Overview
7.3.3 Regeneus Canine Stem Cell Therapy Major Product Offerings
7.3.4 Regeneus Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.3.5 Regeneus Key News
7.4 Aratana Therapeutics
7.4.1 Aratana Therapeutics Corporate Summary
7.4.2 Aratana Therapeutics Business Overview
7.4.3 Aratana Therapeutics Canine Stem Cell Therapy Major Product Offerings
7.4.4 Aratana Therapeutics Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.4.5 Aratana Therapeutics Key News
7.5 Medivet Biologics
7.5.1 Medivet Biologics Corporate Summary
7.5.2 Medivet Biologics Business Overview
7.5.3 Medivet Biologics Canine Stem Cell Therapy Major Product Offerings
7.5.4 Medivet Biologics Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.5.5 Medivet Biologics Key News
7.6 Okyanos
7.6.1 Okyanos Corporate Summary
7.6.2 Okyanos Business Overview
7.6.3 Okyanos Canine Stem Cell Therapy Major Product Offerings
7.6.4 Okyanos Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.6.5 Okyanos Key News
7.7 Vetbiologics
7.7.1 Vetbiologics Corporate Summary
7.7.2 Vetbiologics Business Overview
7.7.3 Vetbiologics Canine Stem Cell Therapy Major Product Offerings
7.7.4 Vetbiologics Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.7.5 Vetbiologics Key News
7.8 VetMatrix
7.8.1 VetMatrix Corporate Summary
7.8.2 VetMatrix Business Overview
7.8.3 VetMatrix Canine Stem Cell Therapy Major Product Offerings
7.8.4 VetMatrix Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.8.5 VetMatrix Key News
7.9 Magellan Stem Cells
7.9.1 Magellan Stem Cells Corporate Summary
7.9.2 Magellan Stem Cells Business Overview
7.9.3 Magellan Stem Cells Canine Stem Cell Therapy Major Product Offerings
7.9.4 Magellan Stem Cells Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.9.5 Magellan Stem Cells Key News
7.10 ANIMAL CELL THERAPIES
7.10.1 ANIMAL CELL THERAPIES Corporate Summary
7.10.2 ANIMAL CELL THERAPIES Business Overview
7.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Major Product Offerings
7.10.4 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.10.5 ANIMAL CELL THERAPIES Key News
7.11 Stemcellvet
7.11.1 Stemcellvet Corporate Summary
7.11.2 Stemcellvet Business Overview
7.11.3 Stemcellvet Canine Stem Cell Therapy Major Product Offerings
7.11.4 Stemcellvet Canine Stem Cell Therapy Revenue in Global Market (2017-2022)
7.11.5 Stemcellvet Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Canine Stem Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Canine Stem Cell Therapy Market Drivers in Global Market
Table 3. Canine Stem Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Canine Stem Cell Therapy in Global Market
Table 5. Top Canine Stem Cell Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Canine Stem Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Canine Stem Cell Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Canine Stem Cell Therapy Product Type
Table 9. List of Global Tier 1 Canine Stem Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Canine Stem Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Canine Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Canine Stem Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Canine Stem Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Canine Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Canine Stem Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Canine Stem Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Canine Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Canine Stem Cell Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Canine Stem Cell Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Canine Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Canine Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Canine Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Canine Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Canine Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 30. VETSTEM BIOPHARMA Corporate Summary
Table 31. VETSTEM BIOPHARMA Canine Stem Cell Therapy Product Offerings
Table 32. VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Cell Therapy Sciences Corporate Summary
Table 34. Cell Therapy Sciences Canine Stem Cell Therapy Product Offerings
Table 35. Cell Therapy Sciences Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Regeneus Corporate Summary
Table 37. Regeneus Canine Stem Cell Therapy Product Offerings
Table 38. Regeneus Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Aratana Therapeutics Corporate Summary
Table 40. Aratana Therapeutics Canine Stem Cell Therapy Product Offerings
Table 41. Aratana Therapeutics Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Medivet Biologics Corporate Summary
Table 43. Medivet Biologics Canine Stem Cell Therapy Product Offerings
Table 44. Medivet Biologics Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Okyanos Corporate Summary
Table 46. Okyanos Canine Stem Cell Therapy Product Offerings
Table 47. Okyanos Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Vetbiologics Corporate Summary
Table 49. Vetbiologics Canine Stem Cell Therapy Product Offerings
Table 50. Vetbiologics Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 51. VetMatrix Corporate Summary
Table 52. VetMatrix Canine Stem Cell Therapy Product Offerings
Table 53. VetMatrix Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Magellan Stem Cells Corporate Summary
Table 55. Magellan Stem Cells Canine Stem Cell Therapy Product Offerings
Table 56. Magellan Stem Cells Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 57. ANIMAL CELL THERAPIES Corporate Summary
Table 58. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product Offerings
Table 59. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Stemcellvet Corporate Summary
Table 61. Stemcellvet Canine Stem Cell Therapy Product Offerings
Table 62. Stemcellvet Canine Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Canine Stem Cell Therapy Segment by Type in 2021
Figure 2. Canine Stem Cell Therapy Segment by Application in 2021
Figure 3. Global Canine Stem Cell Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Canine Stem Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Canine Stem Cell Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Canine Stem Cell Therapy Revenue in 2021
Figure 8. By Type - Global Canine Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Canine Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Canine Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Canine Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 12. US Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Canine Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Canine Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 24. China Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Canine Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Canine Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Canine Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cell Therapy Sciences Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Regeneus Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Aratana Therapeutics Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Medivet Biologics Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Okyanos Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Vetbiologics Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. VetMatrix Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Magellan Stem Cells Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Stemcellvet Canine Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
